Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth.
Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma. In a study published in Proceedings of the ...
New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
The use of cesium-131 “seeds” to combat the reemergence of cancerous tumors has been used in humans for more than 20 years, but a team consisting of current and former Purdue University researchers ...
GammaTile treatment reduces tumor recurrence or death risk by over 50% compared to standard care in operable brain metastases. More than half of GammaTile-treated patients were free from tumor ...
University of Michigan researchers published a study in September, revealing that brain tumors rewire the use of glucose to fuel growth. By removing a specific amino acid from a patient’s diet, tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback